Advances in artificial intelligence (AI) and medical imaging have opened new avenues for the diagnosis and management of prostate cancer. In particular, AI technology can enhance the performance of fusion magnetic resonance imaging-targeted biopsy of the prostate, and has the potential to enhance the usability and precision of this biopsy technique, guide treatment decisions, and further advance prostate cancer care.
European urology oncology. 2023 Aug 14 [Epub ahead of print]
Louis Lenfant, Thomas Seisen, Morgan Rouprêt, Ugo Pinar, Pierre C Mozer
GRC 5, Predictive Onco-Urology, Sorbonne University, Department of Urology, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France; CNRS UMR 7222, INSERM U1150, Institut des Systèmes Intelligents et Robotique, Sorbonne Université, Paris, France. Electronic address: ., GRC 5, Predictive Onco-Urology, Sorbonne University, Department of Urology, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France., GRC 5, Predictive Onco-Urology, Sorbonne University, Department of Urology, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France; CNRS UMR 7222, INSERM U1150, Institut des Systèmes Intelligents et Robotique, Sorbonne Université, Paris, France.